[ 1 ] Virally M, Blicklé JF, Girard J, Halimi S, Simon D, Guillausseau PJ. Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives. Diabetes Metab 2007;33(4):231–44. link1

[ 2 ] Wright E Jr, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 2006;60(3):308–14. link1

[ 3 ] Ahmad SI, editor. Diabetes: an old disease, a new insight. Nottingham: Springer Science & Business Media; 2013. link1

[ 4 ] Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, et al. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz Med Biol Res 2007;40(8):1037–44. link1

[ 5 ] Gonzalez-Franquesa A, Burkart AM, Isganaitis E, Patti ME. What have metabolomics approaches taught us about type 2 diabetes? Curr Diab Rep 2016;16(8):74. link1

[ 6 ] Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009;373(9682):2215–21. link1

[ 7 ] Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87(1):4–14. link1

[ 8 ] Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol 2012;8 (4):228–36. link1

[ 9 ] Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States. Report. Atlanta: US Department of Health and Human Services; 2014. link1

[10] [0] American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care 2013;36(4):1033–46. link1

[11] McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010;363 (24):2339–50. link1

[12] Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev 2000;16(4):230–6. link1

[13] Jiang M, Lu C, Zhang C, Yang J, Tan Y, Lu A, et al. Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmacol 2012;140 (3):634–42. link1

[14] Guo J, Chen H, Song J, Wang J, Zhao L, Tong X. Syndrome differentiation of diabetes by the traditional Chinese medicine according to evidence-based medicine and expert consensus opinion. Evid Based Complement Alternat Med 2014;2014:492193. link1

[15] Zhang AH, Sun H, Qiu S, Wang XJ. Recent highlights of metabolomics in Chinese medicine syndrome research. Evid Based Complement Alternat Med 2013;2013:402159. link1

[16] Ramautar R, Berger R, Van der Greef J, Hankemeier T. Human metabolomics: strategies to understand biology. Curr Opin Chem Biol 2013;17(5):841–6. link1

[17] Wei H, Pasman W, Rubingh C, Wopereis S, Tienstra M, Schroen J, et al. Urine metabolomics combined with the personalized diagnosis guided by Chinese medicine reveals subtypes of pre-diabetes. Mol Biosyst 2012;8(5):1482–91. link1

[18] Wu T, Yang M, Wei HF, He SH, Wang SC, Ji G. Application of metabolomics in traditional Chinese medicine differentiation of deficiency and excess syndromes in patients with diabetes mellitus. Evid Based Complement Alternat Med 2012;2012:968083. link1

[19] He M, Sun M, Van Wijk E, Van Wietmarschen H, Van Wijk R, Wang Z, et al. A Chinese literature overview on ultra-weak photon emission as promising technology for studying system-based diagnostics. Complement Ther Med 2016;25:20–6. link1

[20] Van Wijk R, Van der Greef J, Van Wijk E. Human ultraweak photon emission and the yin yang concept of Chinese medicine. J Acupunct Meridian Stud 2010;3(4):221–31. link1

[21] Ives JA, Van Wijk EP, Bat N, Crawford C, Walter A, Jonas WB, et al. Ultraweak photon emission as a non-invasive health assessment: a systematic review. PLoS One 2014;9(2):e87401. link1

[22] Van Wijk R, Van Wijk EP, Van Wietmarschen HA, Van der Greef J. Towards whole-body ultra-weak photon counting and imaging with a focus on human beings: a review. J Photochem Photobiol B 2014;139:39–46. link1

[23] Burgos RCR, Van Wijk EPA, Van Wijk R, He M, Van der Greef J. Crossing the boundaries of our current healthcare system by integrating ultra-weak photon emissions with metabolomics. Front Physiol 2016;7:611. link1

[24] Van Wijk R, Van Wijk EP, Wiegant FA, Ives J. Free radicals and low-level photon emission in human pathogenesis: state of the art. Indian J Exp Biol 2008;46 (5):273–309. link1

[25] Cifra M, Pospíšil P. Ultra-weak photon emission from biological samples: definition, mechanisms, properties, detection and applications. J Photochem Photobiol B 2014;139:2–10. link1

[26] Prasad A, Pospíšil P. Linoleic acid-induced ultra-weak photon emission from Chlamydomonas reinhardtii as a tool for monitoring of lipid peroxidation in the cell membranes. PLoS One 2011;6(7):e22345. link1

[27] Kobayashi M, Takeda M, Sato T, Yamazaki Y, Kaneko K, Ito K, et al. In vivo imaging of spontaneous ultraweak photon emission from a rat’s brain correlated with cerebral energy metabolism and oxidative stress. Neurosci Res 1999;34(2):103–13. link1

[28] Sun M, Van Wijk E, Koval S, Van Wijk R, He M, Wang M, et al. Measuring ultraweak photon emission as a non-invasive diagnostic tool for detecting earlystage type 2 diabetes: a step toward personalized medicine. J Photochem Photobiol B 2017;166:86–93. link1

[29] Koek MM, Muilwijk B, Van der Werf MJ, Hankemeier T. Microbial metabolomics with gas chromatography/mass spectrometry. Anal Chem 2006;78(4):1272–81. link1

[30] Van Wietmarschen HA, Van der Greef J, Schroën Y, Wang M. Evaluation of symptom, clinical chemistry and metabolomics profiles during Rehmannia six formula (R6) treatment: an integrated and personalized data analysis approach. J Ethnopharmacol 2013;150(3):851–9. link1

[31] Draisma HHM, Reijmers TH, Bobeldijk-Pastorova I, Meulman JJ, Estourgie-Van Burk GF, Bartels M, et al. Similarities and differences in lipidomics profiles among healthy monozygotic twin pairs. OMICS 2008;12(1):17–31. link1

[32] Van Wijk EPA, Van Wijk R, Bajpai RP, Van der Greef J. Statistical analysis of the spontaneously emitted photon signals from palm and dorsal sides of both hands in human subjects. J Photochem Photobiol B 2010;99(3):133–43. link1

[33] Bajpai RP, Van Wijk EPA, Van Wijk R, Van der Greef J. Attributes characterizing spontaneous ultra-weak photon signals of human subjects. J Photochem Photobiol B 2013;129:6–16. link1

[34] Xia J, Sinelnikov IV, Han B, Wishart DS. MetaboAnalyst 3.0—making metabolomics more meaningful. Nucleic Acids Res 2015;43(W1):W251–7. link1

[35] Worley B, Powers R. Multivariate analysis in metabolomics. Curr Metabolomics 2013;1(1):92–107. link1

[36] Van den Berg RA, Hoefsloot HCJ, Westerhuis JA, Smilde AK, Van der Werf MJ. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 2006;7(1):142. link1

[37] Benkali K, Marquet P, Rérolle JP, Le Meur Y, Gastinel L. A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry. BMC Genomics 2008;9(1):541. link1

[38] Petersen IL, Tomasi G, Sørensen H, Boll ES, Hansen HC, Christensen JH. The use of environmental metabolomics to determine glyphosate level of exposure in rapeseed (Brassica napus L.) seedlings. Environ Pollut 2011;159(10):3071–7. link1

[39] Van Wijk R, Van Wijk EPA, Bajpai RP. Photocount distribution of photons emitted from three sites of a human body. J Photochem Photobiol B 2006;84 (1):46–55. link1

[40] Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13(11):2498–504. link1

[41] Gao J, Tarcea VG, Karnovsky A, Mirel BR, Weymouth TE, Beecher CW, et al. Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks. Bioinformatics 2010;26 (7):971–3. link1

[42] Yin P, Peter A, Franken H, Zhao X, Neukamm SS, Rosenbaum L, et al. Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin Chem 2013;59(5):833–45. link1

[43] Bylesjö M, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, Trygg J. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemom 2006;20(8–10):341–51. link1

[44] Wiklund S, Johansson E, Sjöström L, Mellerowicz EJ, Edlund U, Shockcor JP, et al. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 2008;80(1):115–22. link1

[45] Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014;105(2):141–50. link1

[46] Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011;17(4): 448–53. link1

[47] Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 2007;29(2):99–108. link1

[48] Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 2012;8 (1):615. link1

[49] Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 1991;21 (2):161–7. link1

[50] Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 2005;36(3):232–40. link1

[51] Sjölin J, Hjort G, Friman G, Hambraeus L. Urinary excretion of 1- methylhistidine: a qualitative indicator of exogenous 3-methylhistidine and intake of meats from various sources. Metabolism 1987;36(12):1175–84. link1

[52] He M, Van Wijk E, Van Wietmarschen H, Wang M, Sun M, Koval S, et al. Spontaneous ultra-weak photon emission in correlation to inflammatory metabolism and oxidative stress in a mouse model of collagen-induced arthritis. J Photochem Photobiol B 2005;36(3):232–40. link1

[53] Chuang H, Lee E, Liu Y, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Syst Biol 2007;3(1):140. link1

[54] Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011;12(1):56–68. link1

[55] Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, et al. A network-based analysis of systemic inflammation in humans. Nature 2005;437(7061):1032–7. link1

[56] Morgan D, Oliveira-Emilio HR, Keane D, Hirata AE, Santos da Rocha M, Bordin S, et al. palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line. Diabetologia 2007;50(2):359–69. link1